$BSBR

Banco Santander (Brasil) S.A.

No enriched coverage for $BSBR in the last 7 days.

—
$716K
Ishii Michele Soares
0%
See all $BSBR insider activity →
Low

Viani Ede Ilson sold $290K of BSBR

Viani Ede Ilson (VP Exec Officer) sold 50,000 shares of Banco Santander (Brasil) S.A. (BSBR) at $5.79 ($0.29M total) on 2026-09-22.

Cabral Leonardo Mendes sold $114K of BSBR

Cabral Leonardo Mendes (Officer w/o Specific Desig) sold 20,000 shares of Banco Santander (Brasil) S.A. (BSBR) at $5.68 ($0.11M total) on 2026-09-24.

Saes Edmilson sold $290K of BSBR

Saes Edmilson (VP Exec Officer) sold 50,000 shares of Banco Santander (Brasil) S.A. (BSBR) at $5.79 ($0.29M total) on 2026-09-22.

BSBR sentiment & insider activity

Recent BSBR coverage spans insider activity, market movers and financial news.

In the last 30 days, BSBR insiders filed 5 SEC Form 4 transactions — no purchases and 5 sales ($716K). The most active reporter was Ishii Michele Soares, Officer w/o Specific Desig, with 1 filing.

What's driving BSBR

AlphAI scores every news story that mentions BSBR with an AI model for sentiment and relevance, and aggregates insider trades from Banco Santander (Brasil) S.A.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $BSBR

Score
$CLLSMed

This Cellectis Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Cellectis (NASDAQ:CL

Analysts downgraded several stocks: HSBC cut Banco Santander Brasil (BSBR) to Hold with a $6.2 target; Rosenblatt downgraded Ribbon Communications (RBBN) to Neutral with a $2.2 target; Citizens downgraded Cellectis (CLLS) to Market Perform; Barclays downgraded Scholar Rock (SRRK) to Equal-Weight with a $58 target; Raymond James downgraded Ascendis Pharma (ASND) to Outperform with a $287 target.

Related tickers